BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago PL BioScience Unveils World's First Artificial Human Platelet Lysate Regenerative Medicine Biopharmaceuticals Cell Culture PL BioScience Artificial HPL
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago PL BioScience dévoile le premier lysat plaquettaire humain artificiel au monde Médecine Régénérative Produits Biopharmaceutiques Culture Cellulaire PL BioScience HPL Artificiel
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago JOST Werke SE Approves EUR 1.50 Dividend at 2025 AGM JOST Werke SE Leadership Change Dividend Approval Auditor Appointment AGM 2025
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago JOST Werke SE approuve un dividende de 1,50 € lors de son assemblée générale annuelle de 2025 Changement De Direction JOST Werke SE Approbation Des Dividendes Assemblée Générale Annuelle 2025 Nomination D'un Auditeur
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago BlackBerry Initiates Share Buyback Program Share Buyback TSX Financial Strategy NCIB BlackBerry
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago BlackBerry lance un programme de rachat d'actions Rachat D'actions Stratégie Financière Bourse De Toronto NCIB Mûre
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago Kidoz Inc. Changes Ticker Symbol on TSX Venture Exchange Stock Market Kidoz Inc. TSX Venture AdTech Ticker Change
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago Kidoz Inc. change de symbole boursier à la Bourse de croissance TSX Bourse Kidoz Inc. Bourse De Croissance TSX AdTech Changement De Symbole
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago MIRA Pharmaceuticals Announces Strategic Acquisition of SKNY Shareholder Approval Enterprise Value MIRA Pharmaceuticals SKNY Acquisition Therapeutic Markets
BRIEF published on 05/08/2025 at 14:05, 9 months 14 days ago MIRA Pharmaceuticals annonce l'acquisition stratégique de SKNY Approbation Des Actionnaires MIRA Pharmaceuticals Valeur D'entreprise Acquisition De SKNY Marchés Thérapeutiques
Published on 02/21/2026 at 00:45, 1 day 23 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 23 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 2 days 1 hour ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/22/2026 at 12:19, 12 hours 9 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 14 hours 19 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 12 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 12 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 2 days 5 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 19:29, 2 days 4 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
